De Novo
DEN200066: BioFire Joint Infection (JI) Panel
FDA De Novo · biofire diagnostics, llc · decided Apr 29, 2022
Key facts
| De Novo number | DEN200066 |
|---|---|
| Device name | BioFire Joint Infection (JI) Panel |
| Applicant | biofire diagnostics, llc |
| Product code | QSN |
| Date received | Oct 27, 2020 |
| Decision date | Apr 29, 2022 |
| Decision | granted (DENG) |
| FDA classification | Class II |
| Review panel | Microbiology |
| FEI number | 3002773840 |
At a glance
- None Later 510(k)s citing this De Novo
- 1–9 UDI device identifiers (GUDID)
- 1–9 MAUDE adverse event reports
- None Recall events
- No Decision summary on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About De Novo classification requests
The De Novo pathway classifies novel low- to moderate-risk devices that have no legally marketed predicate; each granted request creates a new classification regulation and product code.
Source: U.S. Food and Drug Administration (FDA), De Novo database · Source date: